Cargando…
LncRNA CASC11 Promotes Hepatocellular Carcinoma Progression via Upregulation of UBE2T in a m(6)A-Dependent Manner
Hepatocellular carcinoma (HCC) is one of the most frequent malignancies and the third leading cause of cancer-related deaths worldwide. Besides, it has been revealed that long non-coding RNA (LncRNA) cancer susceptibility candidate 11 (CASC11) is involved in cancer progression. However, the function...
Autores principales: | Chen, Fei, Li, Meijun, Wang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652064/ https://www.ncbi.nlm.nih.gov/pubmed/34900723 http://dx.doi.org/10.3389/fonc.2021.772671 |
Ejemplares similares
-
LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019) -
LncRNA CASC 2 is upregulated in aphthous stomatitis and predicts the recurrence
por: Lu, Jiaping, et al.
Publicado: (2020) -
The LncRNA CASC11 Promotes Colorectal Cancer Cell Proliferation and Migration by Adsorbing miR-646 and miR-381-3p to Upregulate Their Target RAB11FIP2
por: Zhang, Wei, et al.
Publicado: (2021) -
The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling
por: Sun, Jichun, et al.
Publicado: (2022) -
LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway
por: Hsu, Wenchan, et al.
Publicado: (2019)